CRISPR-Cas9 Library Screening Identifies Novel Molecular Vulnerabilities in


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
25 Aug 2023
Historique:
received: 02 07 2023
revised: 11 08 2023
accepted: 22 08 2023
medline: 11 9 2023
pubmed: 9 9 2023
entrez: 9 9 2023
Statut: epublish

Résumé

In acute lymphoblastic leukemia (ALL), chromosomal translocations involving the

Identifiants

pubmed: 37686014
pii: ijms241713207
doi: 10.3390/ijms241713207
pmc: PMC10487613
pii:
doi:

Substances chimiques

Transcription Factors 0
ARID4B protein, human 0
Antigens, Neoplasm 0
Neoplasm Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Foundation KiKa
ID : Not applicable

Références

Turk J Biol. 2021 Feb 09;45(1):56-64
pubmed: 33597822
Blood. 2007 Oct 1;110(7):2774-5
pubmed: 17881645
Cell Death Dis. 2018 Jan 16;9(2):20
pubmed: 29339728
Biochem Soc Trans. 2016 Aug 15;44(4):1117-34
pubmed: 27528760
Leukemia. 2018 Feb;32(2):323-331
pubmed: 28690313
Curr Opin Hematol. 2002 Jul;9(4):282-7
pubmed: 12042701
Int J Mol Sci. 2022 Jan 24;23(3):
pubmed: 35163213
Future Med Chem. 2022 May;14(10):745-766
pubmed: 35543381
Nat Rev Cancer. 2007 Nov;7(11):823-33
pubmed: 17957188
Dev Cell. 2004 Mar;6(3):437-43
pubmed: 15030765
N Engl J Med. 2023 Apr 27;388(17):1572-1581
pubmed: 37099340
Science. 2002 May 31;296(5573):1646-7
pubmed: 12040180
Cancer Cell. 2011 Jul 12;20(1):66-78
pubmed: 21741597
Science. 2014 Jan 3;343(6166):84-87
pubmed: 24336571
Nat Rev Drug Discov. 2017 Feb;16(2):89-100
pubmed: 28008168
Nat Biotechnol. 2016 Jun;34(6):631-3
pubmed: 27111720
Mol Cell Biol. 2003 Apr;23(8):2942-52
pubmed: 12665591
PLoS Genet. 2012 May;8(5):e1002735
pubmed: 22693453
Leuk Res. 1997 Nov-Dec;21(11-12):1107-14
pubmed: 9444945
J Clin Oncol. 2019 Sep 1;37(25):2246-2256
pubmed: 31283407
J Proteome Res. 2018 Aug 3;17(8):2657-2667
pubmed: 29972300
J Exp Med. 2017 Oct 2;214(10):3085-3104
pubmed: 28899870
Int J Hematol. 2015 Apr;101(4):352-61
pubmed: 25773519
Cell Div. 2010 May 13;5:11
pubmed: 20465793
Onco Targets Ther. 2021 Mar 10;14:1843-1855
pubmed: 33732001
Leukemia. 2021 May;35(5):1279-1290
pubmed: 33623141
Biochem Soc Trans. 2014 Aug;42(4):809-15
pubmed: 25109962
Nat Struct Mol Biol. 2006 Sep;13(9):852-4
pubmed: 16892064
N Engl J Med. 2015 Oct 15;373(16):1541-52
pubmed: 26465987
J Clin Pathol. 2017 Feb;70(2):162-167
pubmed: 27451434
Mol Genet Metab. 2016 Sep;119(1-2):37-43
pubmed: 27380996
Cell Rep. 2013 Jan 31;3(1):116-27
pubmed: 23352661
Hum Pathol. 2018 Mar;73:114-121
pubmed: 29288040
Genome Biol. 2014;15(12):554
pubmed: 25476604
PLoS Genet. 2013;9(12):e1004028
pubmed: 24385926
Nature. 2011 Aug 03;478(7370):524-8
pubmed: 21814200
BMB Rep. 2017 Jun;50(6):308-317
pubmed: 28391780
Nat Cell Biol. 2007 Oct;9(10):1208-15
pubmed: 17891136
Oncotarget. 2014 Dec 30;5(24):12675-93
pubmed: 25544748
Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4152-7
pubmed: 9539705
Nat Protoc. 2017 Apr;12(4):828-863
pubmed: 28333914
Tumour Biol. 2016 Oct;37(10):13455-13467
pubmed: 27465550
Cancer Cell. 2008 Nov 4;14(5):355-68
pubmed: 18977325
Cell Rep. 2021 Nov 23;37(8):110036
pubmed: 34818550
Bio Protoc. 2020 Jul 20;10(14):e3682
pubmed: 33659353
J Biol Chem. 2020 Dec 18;295(51):17738-17751
pubmed: 33454011
Br J Cancer. 2022 Sep;127(4):612-623
pubmed: 35501390
Cell. 2011 Dec 23;147(7):1498-510
pubmed: 22196727
Leukemia. 2018 Feb;32(2):273-284
pubmed: 28701730
Haematologica. 2007 Nov;92(11):1565-8
pubmed: 18024407
Leukemia. 2012 Apr;26(4):682-92
pubmed: 22015773
Biochem Soc Trans. 2016 Oct 15;44(5):1455-1463
pubmed: 27911727
Genom Data. 2016 Jan 06;7:173-4
pubmed: 26981404
Cell Res. 2018 Jun;28(6):690-692
pubmed: 29507396
Blood. 2010 Apr 8;115(14):2835-44
pubmed: 20032505
Cell. 2005 Jun 17;121(6):873-85
pubmed: 15960975
Nat Rev Drug Discov. 2002 Sep;1(9):727-30
pubmed: 12209152
Cell. 1997 May 2;89(3):341-7
pubmed: 9150133
Onco Targets Ther. 2014 Feb 18;7:315-24
pubmed: 24570593
Blood. 2018 Jan 4;131(1):4-5
pubmed: 29301770
Lancet. 2007 Jul 21;370(9583):240-250
pubmed: 17658395
Nat Genet. 2002 Jan;30(1):41-7
pubmed: 11731795
Br J Cancer. 2004 May 17;90(10):1972-5
pubmed: 15138480
Mol Cell Biol. 2003 May;23(10):3456-67
pubmed: 12724404
Leuk Res. 2013 Jun;37(6):705-12
pubmed: 23528261
Nat Commun. 2019 Sep 24;10(1):4332
pubmed: 31551414
Cell Death Discov. 2017 Jul 17;3:17039
pubmed: 28725489
Science. 2014 Nov 28;346(6213):1258096
pubmed: 25430774
Annu Rev Cell Dev Biol. 1997;13:261-91
pubmed: 9442875
Blood. 2005 Oct 1;106(7):2484-90
pubmed: 15956279
Nat Biotechnol. 2015 Jun;33(6):661-7
pubmed: 25961408
Cell Death Dis. 2018 Sep 11;9(9):927
pubmed: 30206237
Blood. 2018 Jan 4;131(1):95-107
pubmed: 29084774
Semin Cell Dev Biol. 2022 Sep 17;:
pubmed: 36127263
Cancer Cell. 2003 Feb;3(2):173-83
pubmed: 12620411
Nature. 2023 Mar;615(7954):920-924
pubmed: 36922593

Auteurs

Pauline Schneider (P)

Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.

Priscilla Wander (P)

Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.

Susan T C J M Arentsen-Peters (STCJM)

Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.

Kirsten S Vrenken (KS)

Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.

Dedeke Rockx-Brouwer (D)

Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.

Fabienne R S Adriaanse (FRS)

Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.

Veerle Hoeve (V)

Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.

Irene Paassen (I)

Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.
Oncode Institute, 3521 AL Utrecht, The Netherlands.

Jarno Drost (J)

Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.
Oncode Institute, 3521 AL Utrecht, The Netherlands.

Rob Pieters (R)

Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.

Ronald W Stam (RW)

Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH